308 related articles for article (PubMed ID: 27429020)
21. Prophylactic Pancreatectomies Carry Prohibitive Mortality at Low-Volume Centers: A California Cancer Registry Study.
Callahan AF; Ituarte PHG; Goldstein L; Warner SG; Woo Y; Singh G; Fong Y; Melstrom LG
World J Surg; 2019 Sep; 43(9):2290-2299. PubMed ID: 31062057
[TBL] [Abstract][Full Text] [Related]
22. Travel distance and its interaction with patient and hospital factors in pancreas cancer care.
Siegel J; Engelhardt KE; Hornor MA; Morgan KA; Lancaster WP
Am J Surg; 2021 Apr; 221(4):819-825. PubMed ID: 32891396
[TBL] [Abstract][Full Text] [Related]
23. Hospital volume and patient outcomes in hepato-pancreatico-biliary surgery: is assessing differences in mortality enough?
Schneider EB; Ejaz A; Spolverato G; Hirose K; Makary MA; Wolfgang CL; Ahuja N; Weiss M; Pawlik TM
J Gastrointest Surg; 2014 Dec; 18(12):2105-15. PubMed ID: 25297443
[TBL] [Abstract][Full Text] [Related]
24. Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes.
Nassour I; Choti MA; Porembka MR; Yopp AC; Wang SC; Polanco PM
Surg Endosc; 2018 Jun; 32(6):2907-2913. PubMed ID: 29280014
[TBL] [Abstract][Full Text] [Related]
25. Hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
La Torre M; Nigri G; Ferrari L; Cosenza G; Ravaioli M; Ramacciato G
Am Surg; 2012 Feb; 78(2):225-9. PubMed ID: 22369834
[TBL] [Abstract][Full Text] [Related]
26. Disparities in Care: Impact of Socioeconomic Factors on Pancreatic Surgery: Exploring the National Cancer Database.
Makar M; Worple E; Dove J; Hunsinger M; Arora T; Oxenberg J; Blansfield JA
Am Surg; 2019 Apr; 85(4):327-334. PubMed ID: 31043190
[TBL] [Abstract][Full Text] [Related]
27. Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head.
Lutfi W; Talamonti MS; Kantor O; Wang CH; Liederbach E; Stocker SJ; Bentrem DJ; Roggin KK; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Sep; 160(3):714-24. PubMed ID: 27422328
[TBL] [Abstract][Full Text] [Related]
28. Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.
Torphy RJ; Friedman C; Halpern A; Chapman BC; Ahrendt SS; McCarter MM; Edil BH; Schulick RD; Gleisner A
Ann Surg; 2019 Dec; 270(6):1147-1155. PubMed ID: 29771723
[TBL] [Abstract][Full Text] [Related]
29. Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
Renz BW; Khalil PN; Mikhailov M; Graf S; Schiergens TS; Niess H; Boeck S; Heinemann V; Hartwig W; Werner J; Bruns CJ; Kleespies A
Int J Surg; 2016 Apr; 28():118-25. PubMed ID: 26906329
[TBL] [Abstract][Full Text] [Related]
30. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer.
White MG; Applewhite MK; Kaplan EL; Angelos P; Huo D; Grogan RH
J Am Coll Surg; 2017 Jul; 225(1):125-136.e6. PubMed ID: 28473189
[TBL] [Abstract][Full Text] [Related]
31. Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers?
Perry LM; Bateni SB; Bold RJ; Hoch JS
J Am Coll Surg; 2021 Jul; 233(1):90-98. PubMed ID: 33766724
[TBL] [Abstract][Full Text] [Related]
32. Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.
Adam MA; Choudhury K; Dinan MA; Reed SD; Scheri RP; Blazer DG; Roman SA; Sosa JA
Ann Surg; 2015 Aug; 262(2):372-7. PubMed ID: 26158612
[TBL] [Abstract][Full Text] [Related]
33. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
[TBL] [Abstract][Full Text] [Related]
34. Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal.
Yermilov I; Bentrem D; Sekeris E; Jain S; Maggard MA; Ko CY; Tomlinson JS
Ann Surg Oncol; 2009 Mar; 16(3):554-61. PubMed ID: 19002528
[TBL] [Abstract][Full Text] [Related]
35. Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma.
Toomey P; Childs C; Luberice K; Ross S; Rosemurgy A
Am Surg; 2013 Aug; 79(8):781-5. PubMed ID: 23896244
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients.
Ahmad SA; Edwards MJ; Sutton JM; Grewal SS; Hanseman DJ; Maithel SK; Patel SH; Bentram DJ; Weber SM; Cho CS; Winslow ER; Scoggins CR; Martin RC; Kim HJ; Baker JJ; Merchant NB; Parikh AA; Kooby DA
Ann Surg; 2012 Sep; 256(3):529-37. PubMed ID: 22868373
[TBL] [Abstract][Full Text] [Related]
37. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer.
Bilimoria KY; Talamonti MS; Wayne JD; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
Arch Surg; 2008 Jul; 143(7):671-8; discussion 678. PubMed ID: 18645110
[TBL] [Abstract][Full Text] [Related]
38. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer.
Eskander MF; de Geus SW; Kasumova GG; Ng SC; Al-Refaie W; Ayata G; Tseng JF
Surgery; 2017 Apr; 161(4):968-976. PubMed ID: 27865602
[TBL] [Abstract][Full Text] [Related]
39. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
